Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) Interest & Investment Income (2024 - 2025)

Historic Interest & Investment Income for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to $545000.0.

  • Connect Biopharma Holdings' Interest & Investment Income fell 5198.24% to $545000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year change of. This contributed to the annual value of $4.5 million for FY2024, which is 1474.25% down from last year.
  • As of Q3 2025, Connect Biopharma Holdings' Interest & Investment Income stood at $545000.0, which was down 5198.24% from $619000.0 recorded in Q2 2025.
  • Connect Biopharma Holdings' 5-year Interest & Investment Income high stood at $1.2 million for Q1 2024, and its period low was $545000.0 during Q3 2025.